A phase 3 study to evaluate earlier treatment of prostate cancer in mid-2022
Latest Information Update: 21 Dec 2021
At a glance
- Drugs Abemaciclib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 21 Dec 2021 New trial record
- 15 Dec 2021 According to a Eli Lilly and Company media release, this trial is planned to initiate in mid-2022.